SCHEMBL23535686

SCHEMBL23535686

O=C(O)c1ccc2cc(=O)[nH]cc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
ALDH1A1 P00352 1/20 0.49
HPGD P15428 1/20 0.49
ENPP2 Q13822 1/20 0.49
HSD17B10 Q99714 1/20 0.49
PTPN1 P18031 2/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
RARB P10826 3/20 0.40
RARG P13631 3/20 0.40
RARA P10276 2/20 0.40
GRIN2D O15399 1/20 0.40
GRIN2A Q12879 1/20 0.40
GRIN2B Q13224 1/20 0.40
GRIN2C Q14957 1/20 0.40
CYP26A1 O43174 1/20 0.40
CYP26B1 Q9NR63 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30040715 0.84 LCK (0.55) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL23535839 0.80 POLB (0.55) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL29359975 0.79 KDM4E (0.68) KDM4EALDH1A1HPGDENPP2HSD17B10
SCHEMBL29594563 0.79 KDM4E (0.68) KDM4EALDH1A1HPGDENPP2HSD17B10
SCHEMBL6916181 0.79 KDM4E (0.68) KDM4EALDH1A1HPGDENPP2HSD17B10
SCHEMBL18758 0.79 KDM4E (0.68) KDM4EALDH1A1HPGDENPP2HSD17B10
SCHEMBL2222987 0.78 KDM4E (0.52) KDM4EALDH1A1HPGDENPP2HSD17B10
Bicarbonate SCHEMBL6557215 0.77 KDM4E (0.65) KDM4EALDH1A1HPGDENPP2HSD17B10
Terephthalic Acid SCHEMBL2846917 0.77 TSHR (0.67) KDM4EALDH1A1HPGDENPP2HSD17B10
SCHEMBL20942846 0.77 KDM4E (0.65) KDM4EALDH1A1HPGDENPP2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115427035-B ENL/AF9 YEATS inhibitors 洛克菲勒大学 2025-04-22 CN disclosed
US-20230027198-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY 2023-01-26 US disclosed
US-20230027198-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY 2023-01-26 US disclosed
CN-115427035-A ENL/AF9YEATS inhibitors 洛克菲勒大学 2022-12-02 CN disclosed
EP-4076440-A1 INHIBITORS OF ENL/AF9 YEATS The Rockefeller University (US) 2022-10-26 EP disclosed
WO-2021127166-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY (US) 2021-06-24 WO disclosed
WO-2021127166-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY (US) 2021-06-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230027198-A1 INHIBITORS OF ENL/AF9 YEATS MLLT3, YEATS2, MLLT1 KDM4E 84/4885ALDH1A1 2425/4885HPGD 3998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.